Literature DB >> 16674952

Pigment epithelium-derived factor (PEDF) inhibits advanced glycation end product (AGE)-induced C-reactive protein expression in hepatoma cells by suppressing Rac-1 activation.

Takafumi Yoshida1, Sho-ichi Yamagishi, Kazuo Nakamura, Takanori Matsui, Tsutomu Imaizumi, Masayoshi Takeuchi, Takato Ueno, Michio Sata.   

Abstract

Serum levels of advanced glycation end products (AGEs) are associated with an acute phase reactant, C-reactive proteins (CRP) in diabetic patients. However, whether AGEs could directly stimulate hepatic CRP production remains to be elucidated. We found here that AGEs upregulated CRP mRNA levels in cultured Hep3B cells via Rac-1 activation, which was blocked by pigment epithelium-derived factor (PEDF). Our present study suggests that AGEs are one of the potent inducers of CRP and that PEDF may work as an anti-inflammatory agent against AGEs in the liver.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674952     DOI: 10.1016/j.febslet.2006.04.050

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Jun-Ichi Takino; Kentaro Nagamine; Takamitsu Hori; Akiko Sakasai-Sakai; Masayoshi Takeuchi
Journal:  World J Hepatol       Date:  2015-10-18

Review 2.  MEMBRANE TYPE 1-MATRIX METALLOPROTEINASE (MT1-MMP) IDENTIFIED AS A MULTIFUNCTIONAL REGULATOR OF VASCULAR RESPONSES.

Authors:  Hiroshi Ohkawara; Kazuhiko Ikeda; Kazuei Ogawa; Yasuchika Takeishi
Journal:  Fukushima J Med Sci       Date:  2015-09-11

3.  Glycer-AGEs-RAGE signaling enhances the angiogenic potential of hepatocellular carcinoma by upregulating VEGF expression.

Authors:  Junichi Takino; Shoichi Yamagishi; Masayoshi Takeuchi
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

Review 4.  Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Tadashi Ueda; Mikihiro Tsutsumi; Hideyuki Hyogo; Sho-Ichi Yamagishi
Journal:  World J Hepatol       Date:  2014-12-27

5.  The formation of intracellular glyceraldehyde-derived advanced glycation end-products and cytotoxicity.

Authors:  Jun-ichi Takino; Yuka Kobayashi; Masayoshi Takeuchi
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

6.  Cancer malignancy is enhanced by glyceraldehyde-derived advanced glycation end-products.

Authors:  Jun-Ichi Takino; Sho-Ichi Yamagishi; Masayoshi Takeuchi
Journal:  J Oncol       Date:  2010-06-29       Impact factor: 4.375

7.  Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients.

Authors:  Hideyuki Hyogo; Sho-Ichi Yamagishi; Sayaka Maeda; Kei Fukami; Seiji Ueda; Seiya Okuda; Takashi Nakahara; Yuki Kimura; Tomokazu Ishitobi; Kazuaki Chayama
Journal:  Clin Exp Med       Date:  2012-11-23       Impact factor: 3.984

Review 8.  Role of receptor for advanced glycation end products (RAGE) in liver disease.

Authors:  Sho-ichi Yamagishi; Takanori Matsui
Journal:  Eur J Med Res       Date:  2015-02-11       Impact factor: 2.175

9.  Correlation Between Pigment Epithelium-Derived Factor (PEDF) level and Degree of Coronary Angiography and Severity of Coronary Artery Disease in a Chinese Population.

Authors:  Man Li; Shuxia Wang; Yan Zhang; Shouyuan Ma; Ping Zhu
Journal:  Med Sci Monit       Date:  2018-03-25

Review 10.  Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related Diseases.

Authors:  Masayoshi Takeuchi
Journal:  Diagnostics (Basel)       Date:  2016-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.